Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336850 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
A NA study of Liver Diseases, sponsored by Methodist Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06336850 is a NA study of Liver Diseases that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 100 participants, below the 61,155-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06336850, a NA study of Liver Diseases, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06336850
The ClinicalTrials.gov registry entry for NCT06336850 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,155-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement is the first listed.
NCT06336850 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06336850 about?
NCT06336850 is a clinical study titled "Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement". The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
What is the current status of trial NCT06336850?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-12-23. Estimated completion is 2025-01-01.
What conditions does trial NCT06336850 study?
This clinical trial studies the following conditions: Liver Diseases.
What interventions are being tested in trial NCT06336850?
The interventions under investigation include: Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement (PROCEDURE).
Who is sponsoring clinical trial NCT06336850?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336850 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
-
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.